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Laboratories around the world are currently working to fight
glioblastoma. With that being said, the median survival for
glioblastoma patients is still only about 15 months. New and
improved treatments must be created to significantly improve
patient outcomes.

Fig 2. ZIKV infection and antiviral responses. (A-D) qRT-PCR
data showing decreased mRNA expression of IRF1, ISG15, IFIT1,
and IL6 post ZIKV infection.
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BACKGROUND
Glioblastoma (GBM) is the most common and lethal form of
brain cancer. Standard treatment involves surgery,
chemotherapy, and radiation. Tumor recurrence is caused by a
population of glioblastoma stem cells (GSCs) that resist and
survive treatment. There are currently no pharmacological
agents available for specific targeting of GSCs. Zika virus (ZIKV) is
a flavivirus that targets normal neural stem cells in the
developing brain and causes microcephaly. ZIKV also selectively
targets GSCs in a similar manner. We examined the effect of ZIKV
on specific stem cell markers, as well as antiviral responses in
patient derived GSCs.
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OBJECTIVE
The purpose of this study is to understand the oncolytic
mechanism of ZIKV towards glioblastoma cancer stem cells.

METHODS
Glioblastoma patient derived cell lines were acquired from
within our institution and used for the entirety of this study.
Patient derived cell lines were grown in spheres using
supplemented neurocult media. ZIKV strain MR766 was
propagated in Vero cells and viral stock was titrated by plaque
assays. Glioblastoma patient cell lines were infected with ZIKV at
a multiplicity of infection (MOI) of 1. The percentage of infection
was quantified by flow cytometry using a pan-flavivirus antibody.
Western blotting was used to characterize protein expression,
while qRT-PCR was used to quantify gene expression pre and
post ZIKV infection in patient derived cell lines.
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Fig 3. ZIKV infection and cell death & differentiation. (A-B)
qRT-PCR data showing decreased mRNA expression of Caspase 3
and FGF2 post ZIKV infection.

CONCLUSIONS

RESULTS
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Fig 1. ZIKV infection and stem cell markers. (A) Infection
percentage in patient derived cell line at indicated time points.
(B) Western blot showing decreased Sox2 expression post ZIKV
infection. (C) qRT-PCR data highlighting decreased Sox2 and
Nestin mRNA post ZIKV infection. (D) Immunofluorescence
staining showing decreased Sox2 expression post ZIKV infection.

ZIKV causes loss of GSC renewal through decreased Sox2 and
Nestin expression. ZIKV leads to antiviral responses in GSCs
through an increase of multiple IFN-induced genes. Finally, genes
involved in cell death and differentiation are upregulated post
ZIKV infection.

FUTURE DIRECTIONS

Future studies should use RNA sequencing to further analyze
pathways involved in ZIKV infection and replication.
Furthermore, Sox 2 and Nestin should be knocked down and
knocked out. Lastly, inhibition of differentiation pathways should
be studied pre and post ZIKV infection.
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